Factors Associated with COVID-19 Mortality in Elderly Patients in Intensive Care Unit
Author:
ÖZKARAKAŞ Hüseyin1ORCID, DEMİR İsmail2ORCID
Affiliation:
1. UNIVERSITY OF HEALTH SCIENCES, ANKARA KEÇİÖREN EDUCATION AND RESEARCH HOSPITAL, DEPARTMENT OF SURGICAL MEDICAL SCIENCES 2. UNIVERSITY OF HEALTH SCIENCES, ANKARA KEÇİÖREN EDUCATION AND RESEARCH HOSPITAL, DEPARTMENT OF INTERNAL MEDICINE
Abstract
Objectives: Mortality rates in patients with COVID-19 infection admitted to the intensive care unit are influenced by various factors. In this study, we aimed to investigate the mortality rate and factors affecting mortality in patients admitted to the intensive care unit due to COVID-19 infection who had not been vaccinated.
Methods: Our study was conducted retrospectively by scanning patients admitted to the intensive care unit of Izmir Bozyaka Education and Research Hospital of Health Sciences University from the beginning of 2020 to the end of 2022. Patients who were admitted to the intensive care unit were 65 years of age and older with COVID-19 infection. The patients' presenting complaints, degree of lung involvement, laboratory findings, and comorbidities were compared between patients who survived and those who passed away.
Results: A total of 166 patients were evaluated in our study. Of these, 48 patients were discharged, while 118 patients experienced an excitus. The median age (IQR) for discharged patients was 71.5 (8), and for patients who experienced an excitus, it was 78 (15), which was found to be statistically significant (p
Publisher
Dahiliye uzmanlari dernegi (DAHUDER)
Reference25 articles.
1. de Groot RJ, Baker SC, Baric RS, Brown CS, Drosten C, Enjuanes L, Fouchier RAM, Galiano M, Gorbalenya AE, Memish ZA, Perlman S, Poon LLM, Snijder EJ, Stephens GM, Woo PCY, Zaki AM, Zambon M, Ziebuhr J. Commentary: Middle East Respiratory Syndrome Coronavirus (MERS-CoV): Announcement of the Coronavirus Study Group. J Virol. 2013;87(14):7790-7792. doi:10.1128/JVI.01244-13 2. Drosten C, Günther S, Preiser W, van der Werf S, Brodt HR, Becker S, Rabenau H, Panning M, Kolesnikova L, Fouchier RAM, Berger A, Burguière AM, Cinatl J, Eickmann M, Escriou N, Grywna K, Kramme S, Manuguerra JC, Müller S, Rickerts V, Stürmer M, Vieth S, Klenk HD, Osterhaus ADME, Schmitz H, Doerr HW. Identification of a Novel Coronavirus in Patients with Severe Acute Respiratory Syndrome. New England Journal of Medicine. 2003;348(20):1967-1976. doi:10.1056/NEJMoa030747 3. Kuiken T, Fouchier RA, Schutten M, Rimmelzwaan GF, van Amerongen G, van Riel D, Laman JD, de Jong T, van Doornum G, Lim W, Ling AE, Chan PK, Tam JS, Zambon MC, Gopal R, Drosten C, van der Werf S, Escriou N, Manuguerra JC, Stöhr K, Peiris JSM, Osterhaus AD. Newly discovered coronavirus as the primary cause of severe acute respiratory syndrome. The Lancet. 2003;362(9380):263-270. doi:10.1016/S0140-6736(03)13967-0 4. Doraiswamy S, Cheema S, Mamtani R. Older people and epidemics: a call for empathy. Age Ageing. 2020;49(3):493-493. doi:10.1093/ageing/afaa060 5. Garnier‐Crussard A, Forestier E, Gilbert T, Krolak‐Salmon P. Novel Coronavirus (COVID‐19) Epidemic: What Are the Risks for Older Patients? J Am Geriatr Soc. 2020;68(5):939-940. doi:10.1111/jgs.16407
|
|